Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients

Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog Veklury (remdesivir) for the treatment of non-hospitalized ... Read More